180 related articles for article (PubMed ID: 26578796)
21. EPO-R+ myelodysplastic cells with ring sideroblasts produce high erythroferrone levels to reduce hepcidin expression in hepatic cells.
Miura S; Kobune M; Horiguchi H; Kikuchi S; Iyama S; Murase K; Goto A; Ikeda H; Takada K; Miyanishi K; Kato J
Blood Cells Mol Dis; 2019 Sep; 78():1-8. PubMed ID: 31082798
[TBL] [Abstract][Full Text] [Related]
22. The impact of erythroblast enucleation efficiency on the severity of anemia in patients with myelodysplastic syndrome.
An C; Xue F; Sun L; Han H; Zhang Y; Hu Y
Cell Commun Signal; 2023 Nov; 21(1):332. PubMed ID: 37986081
[TBL] [Abstract][Full Text] [Related]
23. Significance of fetal hemoglobin-containing erythroblasts (F blasts) and the F blast/F cell ratio in myelodysplastic syndromes.
Choi JW; Kim Y; Fujino M; Ito M
Leukemia; 2002 Aug; 16(8):1478-83. PubMed ID: 12145688
[TBL] [Abstract][Full Text] [Related]
24. Expression of CD44 and CD35 during normal and myelodysplastic erythropoiesis.
Laranjeira P; Rodrigues R; Carvalheiro T; Constanço C; Vitória H; Matarraz S; Trindade H; Órfão A; Paiva A
Leuk Res; 2015 Mar; 39(3):361-70. PubMed ID: 25582385
[TBL] [Abstract][Full Text] [Related]
25. The molecular pathogenesis of the myelodysplastic syndromes.
Pellagatti A; Boultwood J
Eur J Haematol; 2015 Jul; 95(1):3-15. PubMed ID: 25645650
[TBL] [Abstract][Full Text] [Related]
26. Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
Travaglino E; Benatti C; Malcovati L; Della Porta MG; Gallì A; Bonetti E; Rosti V; Cazzola M; Invernizzi R
Eur J Haematol; 2008 Mar; 80(3):216-26. PubMed ID: 18081721
[TBL] [Abstract][Full Text] [Related]
27. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
28. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
[TBL] [Abstract][Full Text] [Related]
29. Acute myeloid leukaemia and myelodysplastic syndromes with 50% or greater erythroblasts: a diagnostic conundrum.
Wong E; Juneja S
Pathology; 2015 Jun; 47(4):289-93. PubMed ID: 25938365
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial Hspa9/Mortalin regulates erythroid differentiation via iron-sulfur cluster assembly.
Shan Y; Cortopassi G
Mitochondrion; 2016 Jan; 26():94-103. PubMed ID: 26702583
[TBL] [Abstract][Full Text] [Related]
31. Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics.
Rosenberg CA; Bill M; Rodrigues MA; Hauerslev M; Kerndrup GB; Hokland P; Ludvigsen M
Cytometry B Clin Cytom; 2021 Sep; 100(5):554-567. PubMed ID: 33285035
[TBL] [Abstract][Full Text] [Related]
32. [Application of flow cytometry in detecting dysplasia of myelodysplastic syndromes].
Li J; He GS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1069-72. PubMed ID: 23998614
[TBL] [Abstract][Full Text] [Related]
33. Disruption of erythroid nuclear opening and histone release in myelodysplastic syndromes.
Zhao B; Liu H; Mei Y; Liu Y; Han X; Yang J; Wickrema A; Ji P
Cancer Med; 2019 Mar; 8(3):1169-1174. PubMed ID: 30701702
[TBL] [Abstract][Full Text] [Related]
34. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
35. [Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances].
Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):672-7. PubMed ID: 20450725
[TBL] [Abstract][Full Text] [Related]
36. Identification of DOCK4 and its splicing variant as PIP3 binding proteins.
Kanai A; Ihara S; Ohdaira T; Shinohara-Kanda A; Iwamatsu A; Fukui Y
IUBMB Life; 2008 Jul; 60(7):467-72. PubMed ID: 18459162
[TBL] [Abstract][Full Text] [Related]
37. [Analysis on laboratory and clinical characteristics in 65 cases of myelodysplastic syndrome].
Chen BA; Gao C; Ding J; Ding JH; Sun YY; Zhao G; Cheng J; Wang J; Bao W; Song HH; Xia GH; Ma JL; Wu LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1472-6. PubMed ID: 20030929
[TBL] [Abstract][Full Text] [Related]
38. DNA of Erythroid Origin Is Present in Human Plasma and Informs the Types of Anemia.
Lam WKJ; Gai W; Sun K; Wong RSM; Chan RWY; Jiang P; Chan NPH; Hui WWI; Chan AWH; Szeto CC; Ng SC; Law MF; Chan KCA; Chiu RWK; Lo YMD
Clin Chem; 2017 Oct; 63(10):1614-1623. PubMed ID: 28784691
[TBL] [Abstract][Full Text] [Related]
39. Purification of Bone Marrow Clonal Cells from Patients with Myelodysplastic Syndrome via IGF-IR.
He Q; Chang CK; Xu F; Zhang QX; Shi WH; Li X
PLoS One; 2015; 10(10):e0140372. PubMed ID: 26469401
[TBL] [Abstract][Full Text] [Related]
40. Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome.
Cordoba I; González-Porras JR; Nomdedeu B; Luño E; de Paz R; Such E; Tormo M; Vallespi T; Collado R; Xicoy B; Andreu R; Muñoz JA; Solé F; Cervera J; del Cañizo C;
Cancer; 2012 Jan; 118(1):127-33. PubMed ID: 21717439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]